Who we are
MedStar National Rehabilitation Hospital in Washington DC has a robust research program including a variety of inpatient and outpatient studies to improve patient outcomes. We are national leaders in the research field of bladder dysfunction and urinary symptoms that follow nervous system injury or disease.
Our team currently receives funding from the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), Department of Defense (DOD), Craig H Neilsen Foundation, and industry sponsors. The opinions shared on these pages are those of the authors, and no official endorsement of any funding source should be inferred.
Ongoing research projects
Research Project 1 - Wound study
Pressure Injury study to test Effectiveness of a Powder Dressing to Standard of Care Treatment in Stage 2,3, and 4
This study seeks to compare the effectiveness of Altrazeal (Transforming Powder Dressing) in reducing primary dressing changes in the treatment of non-infected Stage 2, 3, and 4 pressure injuries over a 12-week period versus standard of care therapies recommended within the 2019 NPIAP Guidelines.
Participants must be:
- 18 to 85 years of age
- Stage 2, 3 or 4 pressure ulcers
- Wound exudate is mild to moderate
- No active wound infection (clinical diagnosis)
- Able and willing to provide written (not proxy) informed consent
- Clinically stable, as determined by: Medical history, Vital signs, Physical exam, Laboratory testing prior to enrollment
Participants will be in this study for 12 weeks and will have to be seen in person once a week for the duration of the study.
For more information, please visit https://clinicaltrials.gov/study/NCT05496296
If you are interested or have questions, please contact:
Ana Valeria Aguirre Guemez, MD
anavaleria.aguirreguemez@medstar.net
202-877-1875
Research Project 2 - Autonomic dysfunction
Testing a New Device to Track Autonomic Symptoms After Spinal Cord Injury
To use an investigational device (similar to a wristwatch) to measure wrist temperature. The goal is to determine if the device can help predict autonomic dysreflexia.
Participants must:
- Be 18+ years old
- Be admitted to MedStar NRH for inpatient rehabilitation
- Have an SCI at level L3 or above
- Be free of pre existing heart conditions
Participants will be enrolled in the study for the duration of their rehabilitation stay, during which the device will be worn constantly and will continuously sample wrist temperature. Participants will also complete an autonomic function exam at enrollment and at discharge.
If you are interested or have questions, please contact:
Chris Riegner, MPH
christopher.r.riegner@medstar.net
202-892-5857
Project 3 – Bladder instillation study
Gentamicin + Lactobacillus Bladder Flushes for Urinary Symptoms in Intermittent Catheter Users
We are recruiting participants in DC, MD, PA, and VA for a bladder study looking at the use of a combined antibiotic/probiotic bladder flush when experiencing urinary symptoms.
Participants must:
- Be diagnosed with neurogenic bladder (SCI, MS, SB, stroke, etc.)
- Use intermittent catheterization for bladder management
- 18 years or older
- No urinary symptoms at time of enrollment
Objective 1: Participants nationwide will be randomized into a low or high dose bladder wash group to determine whether high or low dose Lactobacillus GG is more effective at re-colonizing the bladder following intravesical gentamicin use for urinary symptoms.
Objective 2: Participants will collect and mail urine samples before, during, and after the combination gentamicin-Lactobacillus washes to determine the effect on the urine.
For more information, please visit https://clinicaltrials.gov/study/NCT07643974
If you are interested or have questions, please contact:
Chris Riegner, MPH
christopher.r.riegner@medstar.net
202-892-5857
Research Project 4 – UTI diagnosis and treatment study
Assessing a Faster Way to Diagnose and Treat Urinary Tract Infections in People Who Use Catheters
A rapid diagnostic tool for urinary tract infection in spinal cord injury and neurogenic lower urinary tract dysfunction using a catheter[IL2.1] We are recruiting participants in the Washington DC metropolitan area for a bladder study. The study will examine how a rapid diagnostic tool (Jiddu) may help improve treatment decisions for urinary tract infections (UTIs).
Participants must:
- Be 18 years or older
- Diagnosed with neurogenic bladder due to SCI
- Using indwelling catheter for bladder management (urethral or suprapubic catheterization
- Presenting for suspected UTI
For more information, please visit https://clinicaltrials.gov/study/NCT07784829
If you are interested or have questions, please contact:
Madison Hughes, MS
madison.r.hughes@medstar.net
845-260-1577
Research Project 5– Urine collection study
Validating the Jiddu Analyzer for Urine Bacterial Growth in Neurogenic Lower Urinary Tract Dysfunction
Short Title: A New Device to Detect Bacteria in Urine in People With Neurogenic Bladder
We are recruiting participants in the Washington DC metropolitan area for a bladder study. The study will examine urine samples up to 5 timepoints from each participant. The specific aim for this study is to establish a reproducible analysis protocol.
Participants must:
- Be 18 years or older
- Diagnosed with neurogenic bladder (SCI, MS, SB, stroke, etc.)
If you are interested or have questions, please contact:
Ana Valeria Aguirre Guemez, MD
anavaleria.aguirreguemez@Medstar.net
202-877-1875
Research Project 6 – Bladder instillation interview
Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms
The purpose of this study is to determine perspectives of patients and caregivers on various types of intravesical instillations for urinary health. The aim is to identify perceived benefits, barriers, and opportunities related to Lactobacillus and/or gentamicin instillations.
Participants must:
- Be 18 years or older
- Diagnosed with neurogenic bladder (SCI, MS, SB, stroke, etc.)
- Using intermittent catheterization for bladder management
- Have experience of using Lactobacillus and/or Gentamicin bladder instillations
OR
- Caregivers with experience facilitating any type of bladder instillations
If you are interested or have questions, please contact:
Chris Riegner, MPH
christopher.r.riegner@medstar.net
202-892-5857
Research Project 7 – Bladder instillation study ENROLLMENT ENDED
Comparison of Lactobacillus + Saline Bladder Wash vs. Saline Only Bladder Wash for Urinary Symptoms in Intermittent Catheter Users
The objective of this study is to compare a probiotic + saline bladder wash vs. standard care saline only bladder wash in reducing urinary symptoms.
Participants must:
Be 18 years or older
- Diagnosed with spinal cord injury
- Use intermittent catheter
- History of urinary symptoms or urinary tract infections
For more information, please visit https://clinicaltrials.gov/study/NCT05230511
Upcoming projects
Research Project – Respiratory study
Abdominal Stimulation to Improve Cough After Spinal Cord Injury (COUFUS study)
This study is a randomized, sham controlled, double-blinded multi-center clinical trial to evaluate abdominal FES in adult patients with spinal cord injury to increase the strength of the abdominal wall muscles and improve cough peak flow. Eligible participants will be randomized 1:1 to the VentFree Respiratory Muscle Stimulator or a sham treatment.
Participants must:
- Be 22 years or older
- New non-progressive SCI occurring in the past 3 to 8 weeks.
- A neurological level of injury of C1-T5
- American Spinal Injuries Association Impairment Scale A to C
- Cough peak flow (CPF) of <160 L/min
- Expected to remain in inpatient rehabilitation for at least 3 more weeks
Completed projects
Lactobacillus Bladder Flush for Urinary Symptoms in Indwelling Catheter Users
Objective 1: Participants in the metropolitan Washington, D.C., area will provide two urine samples at least two weeks apart when not experiencing urinary symptoms.
Objective 2: Participants nationwide will be randomized into a low or high dose bladder wash group using an intravesical probiotic called Lactobacillus GG. Instillations will occur when experiencing urinary symptoms.
For more information, please visit https://clinicaltrials.gov/study/NCT04323735
A Mixed Methods Assessment of the Impact of Transcutaneous Tibial Nerve Stimulation (TTNS) on Quality of Life and Participation
Study Objective: The primary objective of this study is to evaluate the burden of Neurogenic Lower Urinary Tract Dysfunction (NLUTD) on Health-related Quality of Life (QOL), determine what constitutes a clinically meaningful difference in Neurogenic Lower Urinary Tract Dysfunction (NLUTD)-related QOL and participation Identify NLUTD user-defined themes regarding bladder function and the effects of TTNS neuromodulation on the daily impacts on one’s life.
For more information, please visit https://clinicaltrials.gov/study/NCT04248322
Intravesical L. crispatus: Clinical Safety and Microbiome Evaluation in Intermittent Catheter Users
To find out if a probiotic bladder treatment with L. crispatus is safe and easy for people to use. The goal is to see if it can help treat urinary symptoms and without using antibiotics.
For more information, please visit https://clinicaltrials.gov/study/NCT07308808
Resources
Fact sheets
Bladder Buzz Podcast
Lay Audience Summaries
Bladder Rehab Buzz Newsletter
Recursos en Español
Ficha informativa
-
¿Qué es la disfunción neurógena de las vías urinarias inferiores?
-
Control de la disfunción neurógena de las vías urinarias inferiores
-
¿Cuáles son los síntomas de la disfunción neurogénica del tracto urinario inferior?
-
¿Qué es la disfunción neurógena de las vías urinarias inferiores?
-
Disfunción neurógena de las vías urinarias inferiores hipoactiva
Podcasts en Español
Urinary symptom questionnaires
The spinal cord injury research team at MedStar National Rehabilitation Hospital has developed a series of tools to better help monitor urinary symptoms. The Urinary Symptom Questionnaire for Neurogenic Bladder (USQNB)s were developed for individuals with neurogenic bladder due to Spinal Cord Injury (SCI), Spina Bifida (SB), Multiple Sclerosis(MS) or other neurological diseases. These questionnaires will guide you to make informed decisions on how to manage your symptoms.
-
Intermittent Catheterization (USQNB-IC)
-
Indwelling Catheterization (USQNB-IDC)
-
Voiding (USQNB-V)
Cuestionarios en Español
-
Cateterismo intermitente (USQNB-IC)
-
Catéter permanente (USQNB-IDC)
-
Vaciamiento (USQNB-V)
Publications
-
The urine microbiome of healthy men and women differs by urine collection method
Hsieh M, Groah SL. The urine microbiome of healthy men and women differs by urine collection method. Int Neurourology J 2020 (in press)
-
Symptom and urinalysis-based approach to diagnosing urinary tract infections in children with neuropathic bladders
Forster CS, Wang J. Symptom and urinalysis-based approach to diagnosing urinary tract infections in children with neuropathic bladders. Pediatric Nephrology. In press. PMID: 31919595
-
The diagnosis of UTI in the neuropathic bladder
Forster CS, Pohl H. The diagnosis of UTI in the neuropathic bladder: Changing the paradigm to include the microbiome. Topics in Spinal Cord Injury Rehab, 2019, 25(3):222-227. PMID: 31548789.
-
A single intravesical instillation of probiotics is safe in children and adults with neuropathic bladder
Forster C, Hsieh MH, Perez-Losada M, Caldovic L, Pohl H, Ljungberg IH, Sprague B, Stroud C, Groah SL. A single intravesical instillation of probiotics is safe in children and adults with neuropathic bladder: A phase Ia clinical trial. JSCM 2019 (in press)
-
Effects of intravesical Lactobacillus Rhamnosus GG on urinary Symptom Burden in People with Neurogenic Lower Urinary Tract Dysfunction
Tractenberg RE*, Groah SL*, Frost JK, Rounds AK, Davis E, Ljungberg IH, Schladen MM. Effects of intravesical Lactobacillus Rhamnosus GG on urinary Symptom Burden in People with Neurogenic Lower Urinary Tract Dysfunction. PMR 2019 (under review)
-
Antibiotic prophylaxis prescribing patterns of pediatric urologists for children with vesicoureteral reflux and other congenital anomalies of the kidney and urinary tract
Hamdy R, Pohl H, Forster CS. Antibiotic prophylaxis prescribing patterns of pediatric urologists for children with vesicoureteral reflux and other congenital anomalies of the kidney and urinary tract. Urology. In press. PMID: 31758980
-
The Utility of DNA Next Generation Sequencing and Expanded Quantitative Urine Culture in the Diagnosis and Management of Chronic or Persistent Lower Urinary Tract Symptoms
Gasiorek M, Hsieh H, Forster CS. The Utility of DNA Next Generation Sequencing and Expanded Quantitative Urine Culture in the Diagnosis and Management of Chronic or Persistent Lower Urinary Tract Symptoms. The Journal of Clinical Microbiology. In press. PMID: 31619534
-
Intravesical Lactobacillus Rhamnosus GG is Safe and Well-Tolerated in Adults and Children with Neurogenic Lower Urinary Tract Dysfunction
Groah SL, Rounds AK, Ljungberg IH, Sprague B, Frost J, Tractenberg RE. Intravesical Lactobacillus Rhamnosus GG is Safe and Well-Tolerated in Adults and Children with Neurogenic Lower Urinary Tract Dysfunction: First-in-Human Trial. Ther Adv Urol 2019;11:1-13
-
Bladder Neuromodulation in Acute Spinal Cord Injury via Transcutaneous Tibial Nerve Stimulation
Stampas A, Gustafson K, Korupolu R, Smith C, Zhu L, Li S. Bladder Neuromodulation in Acute Spinal Cord Injury via Transcutaneous Tibial Nerve Stimulation: Cystometrogram and Autonomic Nervous System Evidence From a Randomized Control Pilot Trial. Front Neurosci 19;13:119. Feb 2019
-
Feasibility of Self-Administered Neuromodulation in Spinal Cord Injury Neurogenic Bladder
Int Neurourology J Stampas A, Khavari R, Frontera JE, Groah SL. Feasibility of Self-Administered Neuromodulation in Spinal Cord Injury Neurogenic Bladder. Int Neurourology J 2019 Sep;23(3):249-256.
-
Safety, Feasibility, and Efficacy of Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury Neurogenic Bladder
Stampas A, Korupolu R, Zhu L, Smith CP, Gustafson K. Safety, Feasibility, and Efficacy of Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury Neurogenic Bladder: A Randomized Control Pilot Trial. Neuromodulation. Oct 3 2018.
-
Pediatric Acute Kidney Injury
Roy JP, Forster CS. Clinical Progress Note: Pediatric Acute Kidney Injury. Journal of Hospital Medicine. E pub Aug 16, 2019. PMID: 31433778.
-
Association of Systemic Antimicrobials with the Expression of Beta-Lacatamases in Bacteria Cultured from Urological Patients
Forster CS, Powell EA, Deburger B, Courter J, Haslam DB, and Mortensen JE. Association of Systemic Antimicrobials with the Expression of Beta-Lacatamases in Bacteria Cultured from Urological Patients. Diagnostic Microbiology and Infectious Disease, 2019, 94(4): 391-394. PMID: 30890298
-
Identification of Urinary CD44 and Prosaposin as Specific Biomarkers of Urinary Tract Infections in Children with Neurogenic Bladders
Forster CS, Haffey WD, Bennett M, Greis KD, and Devarajan P. Identification of Urinary CD44 and Prosaposin as Specific Biomarkers of Urinary Tract Infections in Children with Neurogenic Bladders. Biomarker Insights, 2019 Mar 15;1. PMID: 30906192
-
The Association Between Urodynamic Parameters and Urine NGAL Concentrations in Children with Neurogenic Bladders
Forster CS, Goldstein S, Pohl H, and Jackson E. The Association Between Urodynamic Parameters and Urine NGAL Concentrations in Children with Neurogenic Bladders. Journal of Pediatric Urology, Epub 2019; Jan 23. PMID: 30799170
-
Variation in the Diagnosis of Urinary Tract Infection in Children with Neurogenic Bladders between Subspecialists
Forster CS, Jackson E, and Goldstein S. Variation in the Diagnosis of Urinary Tract Infection in Children with Neurogenic Bladders between Subspecialists. Journal of Pediatric Urology, 2018 Dec;14(6):567.e1-567.e6. PMID: 30177384
-
Identification of Burkholderia fungorum in the urine of an individual with spinal cord injury and augmentation cystoplasty using 16s sequencing
Nally E, Groah SL, Perez-Losada M, Caldovic L, Ljungberg IH, Sprague B, Castro-Nallar E, Chandal N, Hsieh M, Pohl H. Identification of Burkholderia fungorum in the urine of an individual with spinal cord injury and augmentation cystoplasty using 16s sequencing: Co-pathogen or innocent bystander? Spinal Cord Series Cases 2018 Sep 21;4:85. Doi: 10.1038/s41394-018-0115-2.
-
Predictive Ability of NGAL in Identifying Urinary Tract Infection in Children with Neurogenic Bladders
Forster CS, Elizabeth Jackson, Qing Ma, Michael Bennett, Samir Shah, and Stuart Goldstein. Predictive Ability of NGAL in Identifying Urinary Tract Infection in Children with Neurogenic Bladders. Pediatric Nephrology, 2018; 33(8): 1365-1374. PMID: 29532235
-
Uropathogens and Pyuria in Children with Neurogenic Bladders
Forster CS, Shaikh N, Hoberman A, Jackson E. Uropathogens and Pyuria in Children with Neurogenic Bladders. Pediatrics, 2018;142(2). PMID: 29618582
-
Preliminary validation of a Urinary Symptom Questionnaire for individuals with Neuropathic Bladder using Intermittent Catheterization (USQNB-IC)
Tractenberg RE, Groah SL, Rounds MK, Ljungberg IH, Schladen MM. Preliminary validation of a Urinary Symptom Questionnaire for individuals with Neuropathic Bladder using Intermittent Catheterization (USQNB-IC): A patient-centered patient reported outcome. PLoS ONE 2018;13(7):e0197568.
-
Evaluation of functional outcomes in traumatic spinal cord injury with rehabilitation-acquired urinary tract infections
Stampas A, Dominick E, Zhu L. Evaluation of functional outcomes in traumatic spinal cord injury with rehabilitation-acquired urinary tract infections: A retrospective study. J Spinal Cord Med 3:1-14. Apr 2018
-
The role of the genitourinary microbiome in pediatric urology.
Gerber DC, Forster CS, Hsieh M. The role of the genitourinary microbiome in pediatric urology: a review. Current Urology Reports. 2018 Feb 22;19(1):13. PMID: 29468401
-
Maintaining primacy of the patient perspective in the development of patient-centered patient reported outcomes
Tractenberg RE, Garver A, Ljungberg IH, Schladen MM, Groah SL Maintaining primacy of the patient perspective in the development of patient-centered patient reported outcomes.
PLoS ONE 2017;12(3): e0171114.doi:10.1371/journal.pone.0171114 -
Does NGAL Reduce Cost?
Parikh A, Rizzo J, Chalfin D, Canetta P, Forster CS, Sise M, Marroug O, Singer E, Elger A, Elitok S, Schmidt-Ott K, Barasch J, Nickolas T. Does NGAL Reduce Cost? A Cost Analysis of Urine NGAL and Serum Creatinine for Acute Kidney Injury. PLOS One, 2017 September; 12(9). PMID:28953968
-
Utility of a Routine Urinalysis in Children Who Require on Clean Intermittent Catheterization
Forster CS, Haslam DB, Jackson E, Goldstein S. Utility of a Routine Urinalysis in Children Who Require on Clean Intermittent Catheterization. Journal of Pediatric Urology, 2017 October;13(5): 488.e1-488.e5. PMID 28284733
-
Urinary NGAL Deficiency in Recurrent Urinary Tract Infections
Forster CS, Johnson K, Patel V, Rodig N, Barasch J, Bachur R, Lee R. Urinary NGAL Deficiency in Recurrent Urinary Tract Infections. Pediatric Nephrology, 2017 June; 32(6): 1077-80. PMID 28210838
-
Unique Transcriptional Programs Identify Subtypes of “Acute Kidney Injury”
Xu K, Rosenthal P, Paragas N, Hinze C, Gao X, Merth M, Forster CS, Deng R, Bruck E, Boles RW, Tornato A, Jones M, Konig J, Gopal T, D’Agati V, Erdjument-Bromage H, Saggi S, Wagener G, Schmidt-Ott K, Tattonetti N, Tempst P, Oliver J, Guarnieri P, Barasch J. Unique Transcriptional Programs Identify Subtypes of “Acute Kidney Injury”. Journal of the American Society of Nephrology, 2017 June; 28(6): 1729-40. PMID: 28028135
-
Frequency of Multidrug-Resistant Organisms Cultured From Urine of Children Undergoing Clean Intermittent Catheterization
Forster CS, Courter J, Jackson E, Mortensen J, Haslam D. Frequency of Multidrug-Resistant Organisms Cultured From Urine of Children Undergoing Clean Intermittent Catheterization. Journal of the Pediatric Infectious Disease Society, 2017 Nov 24;6(4):332-338. PMID: 29186590
-
Redefining healthy urine
J Urol 2016;196(2):Groah SL, Perez-Losada M, Caldovic L, Ljungberg IH, Sprague B, Castro-Nallar E, Chandal N, Hsieh M, Pohl H. Redefining healthy urine: a cross-sectional exploratory metagenomic study of people with and without bladder dysfunction. J Urol 2016;196(2):579-87..
-
Right Test, Wrong Patient
Forster CS, Herbst L, Jerardi KE, Brady P. Right Test, Wrong Patient: Biomarkers and Value. Hospital Pediatrics, 2016 May; 6(5):315-7. PMID 27052032.
Meet our team
Suzanne Groah, MD, MSPH
Dr. Groah is the Project Director for the RRTC and National Capital Spinal Cord Injury Model System
Principal Investigator for research project 1
Co-Principal Investigator for research project 2
Dr. Groah the Director of the Spinal Cord Injury and Disease Rehabilitation and Recovery Program (inpatient, outpatient, and day program) and the Director of Spinal Cord Injury Research at MedStar National Rehabilitation Hospital, as well as Professor of Rehabilitation Medicine at Georgetown University.
Amanda Garver, DO
Principal Investigator on project 3.
Dr. Garver is a Physician Researcher offering outpatient services to the Spinal Cord Injury population in both Baltimore and Washington, DC. Her research continues the work of Dr. Groah and the rest of the Bladder Rehabilitation Research Training Center Team, focusing on bladder symptoms, diagnosis of UTI, and optimizing treatment. Her research interests include improving diagnosis and management of secondary conditions for patients with Spinal Cord Injury, Multiple Sclerosis, and Spina Bifida. She completed her PM&R Residency at the University of Cincinnati and her SCI Fellowship at University of Pittsburgh Medical Center.
Ana Valeria Aguirre, MD
Dr. Aguirre is an early career physician and Research Fellow at MedStar NRH. She is coordinating the SCI model systems database, modular activities and research project 2.
Dr. Aguirre has clinical and research experience in the field of Spinal Cord Injury (SCI), particularly in the development of upper extremity and gait training rehabilitation programs. Currently focusing on strategies and standards to reinforce prevention, diagnosis, and early treatment of complications to improve quality of life of people living with SCI.
Barbara Bregman, PhD
Dr. Bregman is the Co-Project Director of the RRTC and Director of Training.
Dr. Bregman is Director of Education and Training for the MedStar NRH Research Division, and Professor of Neuroscience and Rehabilitation Medicine at Georgetown University (GU). She is currently Co-Program Director of the NIH K12 Neurorehabilitation and Restorative Neuroscience Training Network, which targets the development of junior faculty in neurorehabilitation. As Chair of the Department of Neuroscience at Georgetown University, faculty development and mentorship were key components of her activities.
Carter Denny, MD, MPH
Dr. Denny is an early career physician scientist.
Dr. Denny has a research interests in systems of care delivery and secondary stroke prevention. Dr. Denny has participated in several stroke clinical trials. With the support of a MHRI New Investigator grant, Dr. Denny is now recruiting hypertensive stroke survivors into a home blood pressure self-management study that she designed with the critical appraisal of the MedStar Research Scholars Program. She was awarded an NIH StrokeNet fellowship as a Georgetown junior faculty member for the 2017-2018 academic year.
Catherine Forster, MD
Dr. Forster is an early career physician scientist and Site-PI at Children’s Hospital of Pittsburgh.
Dr. Forster is a pediatric hospitalist at Children’s Hospital of Pittsburgh and an Assistant Professor of Pediatrics at University of Pittsburgh. Her research focuses on identifying improved ways to diagnose urinary tract infections in people with NLUTD. She has expertise in the analysis and interpretation of urine biomarkers, including neutrophil gelatinase-associated lipocalin (NGAL), one of the proteins that will be measured in this study.
Shashwati Geed, PT, PhD
Her research focuses on both rehabilitation outcomes and the neurophysiology of motor function recovery after stroke. Dr. Geed has particular expertise in longitudinal models to measure recovery, clinical trial design in the context of neurorehab, and refining assessments that measure neurorehabilitation outcomes.
Madison Hughes, MS
Ms. Hughes is a Clinical Research Coordinator for research project 2.
Madison has an educational background in biomedical engineering and experience in stroke rehabilitation research. At MedStar NRH, she strives to improve the health outcomes and quality of life in the patients she serves through clinical research.
Emily Leonard, PhD
Dr. Leonard is an early career scientist.
Dr. Leonard’s research background was centered around the improvement of motor function and social-psychological outcomes within a neurological population. As an early Rehabilitation Scientist and Clinical Research Coordinator at MedStar NRH, she focuses on the implementation of clinical research projects to improve patient outcomes and overall quality of life in patients with neurological injury or disease.
Inger Ljungberg, MPH
Ms. Ljungberg is the Director of Research Operations
Inger is the director of research operations at MedStar NRH where she has a long history of both coordinating research studies and serving as the project manager on Dr. Groah’s ongoing research projects. Through her work she has gained invaluable experience in the ability to monitor timely progression of multiple concurrent studies, facilitate cross team communication and supervision of budget expenditures.
Chris Riegner, BA
Mr. Riegner is clinical research coordinator for research project 1, and 3
Chris is a clinical research coordinator with experience in neurological trauma research and mental illness studies. He coordinates recruitment and enrollment for several studies. He received his MPH from George Washington University with a focus on communication of healthcare research to the community.
Argy Stampas, MD
Dr. Stampas is an early career physician researcher.
As a physician researcher, I want to advance the field of rehabilitation using electric stimulation to prevent problems commonly found in spinal cord injury (SCI), including neurogenic bladder and bowel, autonomic dysreflexia, neuropathic pain, and spasticity. In my position as the SCI Medicine Research Director, I can pursue research interests with the support of TIRR Memorial Hermann, UT Health Science Center at Houston, and their research infrastructure to support high-level clinical research. I am involved in the care of hundreds of SCI patients annually, and the institution serves one of the largest SCI populations in the country.
